Orbimed Advisors - TALARIS THERAPEUTICS INC ownership

TALARIS THERAPEUTICS INC's ticker is TALS and the CUSIP is 87410C104. A total of 52 filers reported holding TALARIS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of TALARIS THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$1,064,000
-56.3%
235,995
-4.5%
0.02%
-51.3%
Q1 2022$2,433,000
-35.6%
247,2400.0%0.04%
-20.4%
Q4 2021$3,780,000
+12.7%
247,2400.0%0.05%
+32.4%
Q3 2021$3,353,000
-7.7%
247,2400.0%0.04%0.0%
Q2 2021$3,632,000247,2400.04%
Other shareholders
TALARIS THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Qiming U.S. Ventures Management, LLC 2,932,606$8,240,62310.94%
BML Capital Management, LLC 2,000,000$5,620,0005.16%
Nantahala Capital Management 2,953,129$8,298,2920.71%
GREAT POINT PARTNERS LLC 1,000,000$2,810,0000.51%
Acuitas Investments, LLC 194,547$546,6770.32%
Affinity Asset Advisors, LLC 400,000$1,124,0000.32%
RA Capital Management 2,403,238$6,753,0990.13%
Artal Group S.A. 914,262$2,5690.11%
Blackstone Inc. 8,089,315$22,730,9750.10%
QVT Financial LP 589,314$1,655,9720.09%
View complete list of TALARIS THERAPEUTICS INC shareholders